"N Engl J Med"[journal] 检索结果

1801. Changing Medicare Payment to Strengthen Primary Care.

作者: Douglas B Jacobs.;Christiane T LaBonte.;Meena Seshamani.
来源: N Engl J Med. 2025年392卷3期211-213页

1802. Hairy-Cell Leukemia. Reply.

作者: Brunangelo Falini.;Enrico Tiacci.
来源: N Engl J Med. 2024年391卷24期2388页

1803. Hairy-Cell Leukemia.

作者: David J Hermel.;Alan Saven.
来源: N Engl J Med. 2024年391卷24期2387-2388页

1804. Hairy-Cell Leukemia.

作者: Ilana Reinhold.;Oliver A Cornely.;Jannik Stemler.
来源: N Engl J Med. 2024年391卷24期2386-2387页

1805. Durvalumab in Small-Cell Lung Cancer. Reply.

作者: Suresh Senan.
来源: N Engl J Med. 2024年391卷24期2386页

1806. Durvalumab in Small-Cell Lung Cancer.

作者: Fausto Petrelli.;Lorenzo Dottorini.;Antonio Ghidini.
来源: N Engl J Med. 2024年391卷24期2385-2386页

1807. Durvalumab in Small-Cell Lung Cancer.

作者: Sara Ramella.;Edy Ippolito.;Rolando M D'Angelillo.
来源: N Engl J Med. 2024年391卷24期2385页

1808. Myelodysplasia after Lentiviral Gene Therapy. Reply.

作者: David A Williams.
来源: N Engl J Med. 2024年391卷24期2384页

1809. Myelodysplasia after Lentiviral Gene Therapy.

作者: Howard Lopes Ribeiro.
来源: N Engl J Med. 2024年391卷24期2383-2384页

1810. Myelodysplasia after Lentiviral Gene Therapy.

作者: Akshay Sharma.;Shruthi Suryaprakash.
来源: N Engl J Med. 2024年391卷24期2382-2383页

1811. Myelodysplasia after Lentiviral Gene Therapy.

作者: Donald B Kohn.;Claire Booth.;Luigi Naldini.
来源: N Engl J Med. 2024年391卷24期2382页

1812. Chest Radiography for Presumed Pneumonia in Children.

作者: Julie R Barzilay.;Mark I Neuman.;Todd A Florin.
来源: N Engl J Med. 2024年391卷24期2379-2381页

1813. Levofloxacin Preventive Therapy for Persons Exposed to MDR Tuberculosis.

作者: Susan E Dorman.
来源: N Engl J Med. 2024年391卷24期2376-2378页

1814. Cancer Cachexia and the Brain Stem.

作者: Vickie E Baracos.
来源: N Engl J Med. 2024年391卷24期2373-2376页

1815. Ponsegromab for Cancer Cachexia - A New Dawn for an Old Condition?

作者: Barry J A Laird.;Richard J E Skipworth.
来源: N Engl J Med. 2024年391卷24期2371-2373页

1816. Case 40-2024: A 56-Year-Old Woman with End-Stage Liver Disease and Headache.

作者: Shoshana J Herzig.;Benjamin M Kozak.;Camille N Kotton.;Annemarie E Fogerty.;Sarah E Turbett.
来源: N Engl J Med. 2024年391卷24期2361-2369页

1817. Coronary Subclavian Steal Syndrome.

作者: Mit Chaudhari.;Vishal Sharma.
来源: N Engl J Med. 2024年391卷24期e63页

1818. Nonsurgical Management of Chronic Venous Insufficiency.

作者: Eri Fukaya.;Raghu Kolluri.
来源: N Engl J Med. 2024年391卷24期2350-2359页

1819. Ebola Outbreak Response in the DRC with rVSV-ZEBOV-GP Ring Vaccination.

作者: Jean-Jacques Muyembe.;Hongchao Pan.;Richard Peto.;Abdourahamane Diallo.;Alhassane Touré.;Placide Mbala-Kingebene.;Stéphane H Bateyi Mustafa.;Ndjoloko Tambwe.;Sabue Mulangu.;Steve Ahuka-Mundeke.;Elisabeth Mukamba Musenga.;Godwin Enwere.;Pierre-Stéphane Gsell.;Ira M Longini.;Ximena Riveros Balta.;Chrissy H Roberts.;Michael Marks.;Michel N K Yao.;Abdou Salam Gueye.;Ibrahima-Soce Fall.;Peter Salama.;Michael J Ryan.;Ana Maria Henao-Restrepo.; .
来源: N Engl J Med. 2024年391卷24期2327-2336页

At the beginning of the 2018-2020 outbreak of Ebola virus disease (EVD) in eastern Democratic Republic of Congo (DRC), no vaccine had been licensed. However, cluster-randomized evidence from Guinea in 2015 had indicated that ring vaccination around new cases (targeting contacts and contacts-of-contacts) with the use of single-dose live-replicating rVSV-ZEBOV-GP vaccine reduced EVD rates starting 10 days after vaccination. Thus, ring vaccination was added to the standard control measures for that outbreak.

1820. Levofloxacin Preventive Treatment in Children Exposed to MDR Tuberculosis.

作者: Anneke C Hesseling.;Susan E Purchase.;Neil A Martinson.;Lee Fairlie.;H Simon Schaaf.;Joanna Brigden.;Suzanne Staples.;Diana M Gibb.;Anthony Garcia-Prats.;Francesca Conradie.;Charlotte McGowan.;Charlotte Layton.;Elize Batist.;Anne-Marie Demers.;Samukelisiwe Nyamathe.;Lisa Frigati.;Rebecca Turner.;Trinh Duong.;James A Seddon.
来源: N Engl J Med. 2024年391卷24期2315-2326页

Worldwide, approximately 2 million children younger than 15 years of age are infected with multidrug-resistant (MDR) Mycobacterium tuberculosis, with MDR tuberculosis developing in approximately 30,000 annually. Evidence from randomized, controlled trials on tuberculosis preventive treatment in persons exposed to MDR tuberculosis is lacking.

结果排序

文献格式

出版时间

出版类型

出版语言